ORLANDO, Fla., April 24, 2014 /PRNewswire/ -- Signature Exploration and Production Corp. (OTCQB: SXLP) has changed its name to GrowBlox Sciences, Inc. The Company expects to be trading under its new name and ticker symbol "GBLX" on April 28, 2014.
About GrowBlox Sciences, Inc.
GrowBlox has developed a proprietary indoor growing chamber specifically designed for medical cannabis cultivation in which cannabis can be grown hydroponically under completely controlled conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal grade product. Further, the controlled environment makes monitoring growth and measurement of actual production simple, automatic and precise. The Company believes that the advantages of a controlled environment over typical, haphazard outdoor or greenhouse growing will enable the public, and the nutriceutical and pharmaceutical industries, to embrace cannabis for what it is and has always been—an effective treatment for glaucoma, epilepsy, pain and many other maladies. We believe GrowBlox Sciences will set the new standard for consistent medical cannabis production in all legal states.
Therefore, in addition to bringing its proprietary growing technology to market, the company intends to pursue a strategy of entering the nutriceutical market, and ultimately the botanical pharmaceutical market, in part by providing a pure product with specific characteristics—through advanced plant genetics—as may be considered effective for particular uses of cannabis.
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact: GlowBlox Sciences, Inc., 844-843-2569.
SOURCE GrowBlox Sciences, Inc.